Literature DB >> 16385140

Phosphorylation of AMPA receptors: mechanisms and synaptic plasticity.

John Q Wang1, Anish Arora, Lu Yang, Nikhil K Parelkar, Guochi Zhang, Xianyu Liu, Eun Sang Choe, Limin Mao.   

Abstract

The ionotropic alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor is densely distributed in the mammalian brain and is primarily involved in mediating fast excitatory synaptic transmission. Recent studies in both heterologous expression systems and cultured neurons have shown that the AMPA receptor can be phosphorylated on their subunits (GluR1, GluR2, and GluR4). All phosphorylation sites reside at serine, threonine, or tyrosine on the intracellular C-terminal domain. Several key protein kinases, such as protein kinase A, protein kinase C, Ca2+/calmodulin-dependent protein kinase II, and tyrosine kinases (Trks; receptor or nonreceptor family Trks) are involved in the site-specific regulation of the AMPA receptor phosphorylation. Other glutamate receptors (N-methyl-d-aspartate receptors and metabotropic glutamate receptors) also regulate AMPA receptors through a protein phosphorylation mechanism. Emerging evidence shows that as a rapid and short-term mechanism, the dynamic protein phosphorylation directly modulates the electrophysiological, morphological (externalization and internalization trafficking and clustering), and biochemical (synthesis and subunit composition) properties of the AMPA receptor, as well as protein-protein interactions between the AMPA receptor subunits and various intracellular interacting proteins. These modulations underlie the major molecular mechanisms that ultimately affect many forms of synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16385140     DOI: 10.1385/MN:32:3:237

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  98 in total

1.  Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo.

Authors:  G L Snyder; P B Allen; A A Fienberg; C G Valle; R L Huganir; A C Nairn; P Greengard
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

2.  Protein kinases and phosphatase inhibitors mediating long-term desensitization of glutamate receptors in cerebellar Purkinje cells.

Authors:  M Ito; L Karachot
Journal:  Neurosci Res       Date:  1992-06       Impact factor: 3.304

3.  Activation of protein kinase C induces a long-term depression of glutamate sensitivity of cerebellar Purkinje cells. An in vitro study.

Authors:  F Crepel; M Krupa
Journal:  Brain Res       Date:  1988-08-23       Impact factor: 3.252

Review 4.  Glutamate receptors in the mammalian central nervous system.

Authors:  S Ozawa; H Kamiya; K Tsuzuki
Journal:  Prog Neurobiol       Date:  1998-04       Impact factor: 11.685

5.  Control of GluR1 AMPA receptor function by cAMP-dependent protein kinase.

Authors:  T G Banke; D Bowie; H Lee; R L Huganir; A Schousboe; S F Traynelis
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

6.  Multiple mechanisms for the potentiation of AMPA receptor-mediated transmission by alpha-Ca2+/calmodulin-dependent protein kinase II.

Authors:  Jean Christophe Poncer; Jose A Esteban; Roberto Malinow
Journal:  J Neurosci       Date:  2002-06-01       Impact factor: 6.167

7.  Protein kinases regulate the phosphorylation of the GluR1 subunit of AMPA receptors of spinal cord in rats following noxious stimulation.

Authors:  Li Fang; Jing Wu; Qing Lin; William D Willis
Journal:  Brain Res Mol Brain Res       Date:  2003-10-21

8.  Phosphorylation and modulation of recombinant GluR6 glutamate receptors by cAMP-dependent protein kinase.

Authors:  L A Raymond; C D Blackstone; R L Huganir
Journal:  Nature       Date:  1993-02-18       Impact factor: 49.962

9.  Modulation of dopamine mediated phosphorylation of AMPA receptors by PSD-95 and AKAP79/150.

Authors:  Richard D Swayze; Marie-France Lisé; Joshua N Levinson; Anthony Phillips; Alaa El-Husseini
Journal:  Neuropharmacology       Date:  2004-10       Impact factor: 5.250

Review 10.  Interactions between AMPA receptors and intracellular proteins.

Authors:  S P Braithwaite; G Meyer; J M Henley
Journal:  Neuropharmacology       Date:  2000-04-03       Impact factor: 5.250

View more
  58 in total

1.  Hippocampal GluA1-containing AMPA receptors mediate context-dependent sensitization to morphine.

Authors:  Yan Xia; George S Portugal; Amanda K Fakira; Zara Melyan; Rachael Neve; H Thomas Lee; Scott J Russo; Jie Liu; Jose A Morón
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

2.  Agonist-induced PKC phosphorylation regulates GluK2 SUMOylation and kainate receptor endocytosis.

Authors:  Filip A Konopacki; Nadia Jaafari; Dan L Rocca; Kevin A Wilkinson; Sophie Chamberlain; Philip Rubin; Sriharsha Kantamneni; Jack R Mellor; Jeremy M Henley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-16       Impact factor: 11.205

Review 3.  Posttranslational regulation of AMPA receptor trafficking and function.

Authors:  Wei Lu; Katherine W Roche
Journal:  Curr Opin Neurobiol       Date:  2011-10-14       Impact factor: 6.627

4.  Integrin regulation of cytoplasmic calcium in excitatory neurons depends upon glutamate receptors and release from intracellular stores.

Authors:  C-Y Lin; L G W Hilgenberg; M A Smith; G Lynch; C M Gall
Journal:  Mol Cell Neurosci       Date:  2008-01-17       Impact factor: 4.314

5.  Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens.

Authors:  Michael J Glass; Diane A Lane; Eric E O Colago; June Chan; Stefan D Schlussman; Yan Zhou; Mary Jeanne Kreek; Virginia M Pickel
Journal:  Exp Neurol       Date:  2008-01-26       Impact factor: 5.330

6.  Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid.

Authors:  Alberto Lleó; Raúl Núñez-Llaves; Daniel Alcolea; Cristina Chiva; Daniel Balateu-Paños; Martí Colom-Cadena; Gemma Gomez-Giro; Laia Muñoz; Marta Querol-Vilaseca; Jordi Pegueroles; Lorena Rami; Albert Lladó; José L Molinuevo; Mikel Tainta; Jordi Clarimón; Tara Spires-Jones; Rafael Blesa; Juan Fortea; Pablo Martínez-Lage; Raquel Sánchez-Valle; Eduard Sabidó; Àlex Bayés; Olivia Belbin
Journal:  Mol Cell Proteomics       Date:  2019-01-03       Impact factor: 5.911

7.  Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage.

Authors:  K L Grinnell; J R Bickenbach
Journal:  Cell Prolif       Date:  2007-10       Impact factor: 6.831

Review 8.  The Opioid-Addicted Tetrapartite Synapse.

Authors:  Anna Kruyer; Vivian C Chioma; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2019-06-13       Impact factor: 13.382

Review 9.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

10.  Proteomic analysis of post-translational modifications in conditioned Hermissenda.

Authors:  T Crow; J-J Xue-Bian
Journal:  Neuroscience       Date:  2009-12-01       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.